Randomized clinical study· 1999
The amylin analog pramlintide improves glycemic control and reduces postprandial glucagon concentrations in patients with type 1 diabetes mellitus
Nyholm B|Orskov L|Hove KY|Gravholt CH|Moller N|Alberti KG|Moyses C|Kolterman O|Schmitz O
Metabolism
- PubMed
- 10421239
- Evidence level
- moderate
- Verification
- verified
Summary
A clinical study evaluated pramlintide in adults with type 1 diabetes.
Limitations
Small short-term study|Requires insulin adjustment|Does not generalise to unlicensed analogues or obesity self-use